Skip to main content
Premium Trial:

Request an Annual Quote

Predicine Gets CLIA Certification for Sequencing Lab

NEW YORK (GenomeWeb) — Predicine said today that it has received CLIA certification for its genomic sequencing lab in Hayward, California.

"CLIA certification is a critical step that enables us to work with liquid and tissue biopsy samples while we scale for full commercial launch this year," Predicine Founder and CEO Shidong Jia said in a statement. "We can now participate in a greater variety of therapeutic clinical trials to provide molecular information about the disease status and therapeutic response of a patient at each clinical decision point … [as well as] partner with pharma clients in companion diagnostic development."

Predicine, which closed a $13.5 million Series A round earlier this year, is developing a proprietary technology for the detection of RNA- and DNA-based genetic alterations in blood samples, while building a pipeline of cancer biomarkers. The company also maintains an R&D facility in China where it markets next-generation sequencing-based liquid biopsy diagnostics for lung cancer and prostate cancer in partnership with CloudHealth Genomics.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.